Enhanced solubility of non-steroidal anti-inflammatory drugs by hydroxyl terminated S-triazine based dendrimers

Asian Journal of Pharmaceutical and Clinical Research

Volumn 7, Issue SUPPL. 2, 2014, Pages 156-161

  Patel, Rinkesh M ^a   Patel, Hema N ^a   Gajjar, Dhaval G ^a   Patel, Pravinkumar M ^a  

^a SARDAR PATEL UNIVERSITY   (India)

Author keywords

Dendrimer; Nonsteroidal anti inflammatory drugs; Solubility enhancers; Triazine trichloride

Indexed keywords

DENDRIMER; DIETHANOLAMINE; DIFLUNISAL; IBUPROFEN; KETOPROFEN; N' BIS (4,6 DICHLORO 1,3,5 TRIAZIN 2 YL)HEXANE 1,6 DIAMINE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; HYDROGEN BOND; HYDROPHOBICITY; INFRARED RADIATION; PH; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84903365978     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chen H, Khemtong C, Yang X, Chang X, Gao J. Nanonization strategies for poorly water-soluble drugs. Drug Discov. Today 2011; 16(6-7): 354-360.
2. Lipinski C. Poor aqueous solubility - an industry wide problem in drug discovery. Am. Pharm. Rev 2002; 5: 82-85.
3. Heimbach T. Overcoming poor aqueous solubility of drugs for oral delivery. In Prodrugs (2007); 157-215.
4. Marie R G. Epidemiology of Nonsteroidal Anti-inflammatory Drug-Associated Gastrointestinal Injury. Am. J. Med 1998; 104: 23S-29S.
5. Timothy A C. Nonsteroidal Anti-inflammatory Drugs, Apoptosis, and Colon-Cancer Chemoprevention. Lancet Oncol 2002; 3:166-174.
6. Polisson R. Nonsteroidal Anti-inflammatory Drugs: Practical andTheoretical Considerations in Their Selection, Am. J. Med 1996; 100:31S-36S.
7. Denis M M. Comparative Toxicity of Nonsteroidal Anti- inflammatory Drugs, Am. J. Med 1999; 107 (Suppl. 1): 37-46.
8. Fabrice L, Fabienne P, Myriam M. Binding of Ketoprofen Enantiomersin Various Human Albumin Preparations. J. Pharm. Biomed. Anal 2000; 23: 793-802.
9. Khaleel N Y, Abdulrasool A A, Ghareeb M M, Hussain S A. Solubility and dissolution improvement of Ketoprofen by solid dispersion in polymer and surfactant using solvent evaporation method. Int. J. Pharm.Pharmsci 2011; 3(4):431-435.
10. Vergote G J, Vervaet C, Driessche I V. An oral controlled release matrix pellet formulation containing nanocrystallineKetoprofen. Int. J. Pharm 2001; 219:81-87.
11. Makiko F, Naohide H, Kumi S. Effect of fatty acid esters onpermeation of Ketoprofen through hairless rat skin. Int. J. Pharm 2000; 20:117-125.
12. Umesh G, Hrushikesh B A, Asthana A, and Jain N K. Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement. Biomacromol 2006; 7(3): 649-658.
13. Jain N K and Gupta U, Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability. Expert Opin. Drug Metab. Toxicol 2008; 8:1035-1045.
14. Patel HN, Patel PM. Dendrimer Applications- A Review. Int. J. Pharm. Bio.Sci 2013; 4: 454-463.
15. Milhem O M, Myles C, McKeown N B, D'Emanuele A. Polyamidoamine Starburst® dendrimers as solubility enhancers. Int. J. Pharm 2000; 197:239-241.
16. Yiyun C, Xu T, Rongquiang F. Polyamidoamine dendrimers used as solubility enhancers of Ketoprofen. Eur. J. Med.Chem 2005; 40: 1390-1393.
17. Yiyun C, Tongwen X. Dendrimers as Potential Drug Carriers Part I. Solubilization of Non-Steroidal Anti-Inflammatory Drugs in the Presence of Polyamidoamine Dendrimers. Eur. J. Med.Chem 2005; 40: 1188-1192.
18. Chauhan A S, Sridevi S, Chalasani K B, Jain A K, Jain S K, Jain N K, Diwan PV Dendrimer-mediated transdermal delivery:enhanced bioavailability of indomethacin. J. Control.Rel 2003; 90:335-343.
19. Khopade A J, Caruso F, Tripathi P, Nagaich S, Jain N K. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int. J. Pharm 2002; 232:157-162.
20. Ooya T, Lee J, Park K. Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J. Control. Rel 2003; 93:121-127.
21. Gajjar D, Patel R, Patel H, Patel P M. Designing of Triazine based Dendrimer and Its Application in Removal of Heavy Metal Ions from Water. Chem. Sci. Trans 2014; Accepted.
22. Patel R, Gajjar D, Patel H, Patel PM, Facile Synthesis, Characterization and Properties of Triazine based dendrimer, Int. J. Chem. Sci 2014; 12(2): 1-13.
23. Higuchi T, Connors A.Phase-solubility techniques. In: Advances inAnalytical Chemistry and Instrumentation, New York, JohnWiley; 1965, p117-212.
24. Bansal K K, Kakde D, Gupta U, Jain N K. Development and Characterization of Triazine BasedDendrimers for Delivery of Antitumor Agent. J.Nanosci.Nanomed 2010; 10: 8395-8404.